Clinical Trials Browser

disitamab vedotin × Gynecologic × 1 year × Clear all

NCT06003231 2026-06-01

A Study of Disitamab Vedotin in Previously Treated Solid Tumors That Express HER2

Phase 2 Active not recruiting

GynecologicHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT06540729 2025-07-08

DAB

Phase 2 Recruiting

Ovarian Neoplasms